Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
14.40
-0.10 (-0.69%)
At close: Jan 22, 2026
-12.20%
Market Cap1.49B
Revenue (ttm)428.63M
Net Income (ttm)46.56M
Shares Out103.81M
EPS (ttm)0.45
PE Ratio31.90
Forward PEn/a
Dividend0.11 (0.76%)
Ex-Dividend DateDec 17, 2025
Volume304,816
Average Volume339,784
Openn/a
Previous Close14.50
Day's Range14.30 - 14.80
52-Week Range11.10 - 18.50
Beta0.19
RSI62.56
Earnings DateJan 29, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 313
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILCOPHL
Full Company Profile

Financial Performance

In 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.

Financial Statements